Apyx Medical Corp (APYX)
1.40
-0.03
(-2.10%)
USD |
NASDAQ |
May 01, 16:00
Apyx Medical Free Cash Flow: -5.782M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -5.782M |
September 30, 2023 | -8.149M |
June 30, 2023 | -17.22M |
March 31, 2023 | -18.48M |
December 31, 2022 | -21.29M |
September 30, 2022 | -16.74M |
June 30, 2022 | -14.96M |
March 31, 2022 | -13.72M |
December 31, 2021 | -11.17M |
September 30, 2021 | -12.46M |
June 30, 2021 | -11.31M |
March 31, 2021 | -11.39M |
December 31, 2020 | -16.65M |
September 30, 2020 | -18.72M |
June 30, 2020 | -21.20M |
March 31, 2020 | -22.07M |
December 31, 2019 | -19.78M |
September 30, 2019 | -34.51M |
June 30, 2019 | -30.42M |
March 31, 2019 | -25.20M |
December 31, 2018 | -21.24M |
September 30, 2018 | -2.50M |
June 30, 2018 | -2.296M |
March 31, 2018 | -2.686M |
December 31, 2017 | -4.328M |
Date | Value |
---|---|
September 30, 2017 | -5.514M |
June 30, 2017 | -4.747M |
March 31, 2017 | -3.724M |
December 31, 2016 | -3.123M |
September 30, 2016 | -3.313M |
June 30, 2016 | -4.045M |
March 31, 2016 | -6.45M |
December 31, 2015 | -6.207M |
September 30, 2015 | -5.482M |
June 30, 2015 | -4.153M |
March 31, 2015 | -1.968M |
December 31, 2014 | -1.047M |
September 30, 2014 | -2.452M |
June 30, 2014 | -3.041M |
March 31, 2014 | -3.864M |
December 31, 2013 | -3.124M |
September 30, 2013 | -1.899M |
June 30, 2013 | -2.315M |
March 31, 2013 | -0.243M |
December 31, 2012 | -0.588M |
September 30, 2012 | -0.626M |
June 30, 2012 | -0.434M |
March 31, 2012 | -0.036M |
December 31, 2011 | 1.355M |
September 30, 2011 | 2.263M |
Free Cash Flow Range, Past 5 Years
-34.51M
Minimum
Sep 2019
-5.782M
Maximum
Dec 2023
-17.16M
Average
-16.74M
Median
Sep 2022
Free Cash Flow Benchmarks
Nortech Systems Inc | 0.485M |
Monogram Orthopaedics Inc | -13.61M |
Perspective Therapeutics Inc | -37.98M |
Xtant Medical Holdings Inc | -10.97M |
Asensus Surgical Inc | -64.19M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -2.212M |
Cash from Investing (Quarterly) | -0.093M |
Cash from Financing (Quarterly) | 23.84M |
Free Cash Flow Per Share (Quarterly) | -0.0665 |
Free Cash Flow to Equity (Quarterly) | -26.48M |
Free Cash Flow to Firm (Quarterly) | -1.626M |
Free Cash Flow Yield | -11.93% |